Drugs / AdimFlu-V
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01755364 | Nov 2012 → Jan 2013 | influenza | Adimmune Corporation | Completed | No outcome recorded |
| Phase 3 | NCT01759654 | Oct → Dec 2012 | influenza | Adimmune Corporation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AdimFlu-V | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01755364 ↗ |
| Modality | Vaccine | “Trivalent Virosomal Influenza Vaccine” NCT01755364 ↗ |
| Route | Intramuscular | “by intramuscular injection into the upper arm” NCT01755364 ↗ |